Mirror Biologics, Inc. Announces Additional $20 Million Inve

Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series...

Related Keywords

Kuala Lumpur , Malaysia , Jerusalem , Israel General , Israel , Taiwan , Tampa , Florida , United States , Hong Kong , China , Delaware , Indonesia , Cayman Islands , Thailand , Singapore , Bangkok , Krung Thep Mahanakhon , Michael Har Noy , Biologics Inc , Bradbury Asset Management Hong Kong , Bradbury Group , Bradbury Asset Management Fund , Clinical Research Center , Bradbury Asset Management , Loo See Yuen , Keith Loo , Mirror Biologics , Mirror Effect ,